648 — SoftMedx Healthcare Cashflow Statement
0.000.00%
Last trade - 00:00- HK$531.51m
- HK$532.13m
- HK$68.24m
Annual cashflow statement for SoftMedx Healthcare, fiscal year end - December 31st, HKD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | — |
| Source: | ARS | ARS | ARS | ARS | |
| Standards: | HKAS | HKAS | HKAS | HKAS | — |
| Status: | Final | Final | Final | Final | fx Preliminary |
| Net Income/Starting Line | -24.7 | -16.6 | 14.4 | 328 | — |
| Depreciation | |||||
| Non-Cash Items | 3.99 | 9.96 | -5.97 | -318 | — |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 12.9 | 1.79 | -14.1 | -6.34 | — |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Payable / Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -6.62 | -2.84 | -4.49 | 3.88 | — |
| Capital Expenditures | -0.524 | -0.532 | 0 | — | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -0.173 | 0.203 | -0.845 | 0.188 | — |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.697 | -0.329 | -0.845 | 0.188 | — |
| Financing Cash Flow Items | -0.071 | -0.1 | -0.037 | -0.036 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 9.91 | 2.6 | 10.3 | -3.36 | — |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 2.6 | -0.575 | 4.97 | 0.705 | — |